1975
DOI: 10.1002/cncr.2820360946
|View full text |Cite
|
Sign up to set email alerts
|

A metastasising ameloblastoma associated with renal calculi and hypercalcaemia

Abstract: A young male had an assumed dentigerous cyst marsupialized and later a recurrent ameloblastoma resected. Eleven years later he was admitted with renal stones and hypercalcemia and metastases of the ameloblastoma in the left lung were discovered. Death occurred as a result'of spinal and hepatic spread of his tumor and thrombosis of the renal veins. Renal calcification was demonstrated. The possible causes of the hypercalcaemia which was not associated with a raised serum parathormone or affected by parathyroide… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

1979
1979
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(7 citation statements)
references
References 17 publications
0
5
0
Order By: Relevance
“…Humoral hypercalcemia of malignancy (HHM) is caused most commonly by the humoral action of PTHrP, which is released by tumor cells (9, 10, 12). Malignant ameloblastoma is occasionally accompanied by hypercalcemia with or without metastasis, and several cases have been ascribed to tumor‐derived PTHrP (16, 17, 48, 49). Tumor‐derived PTHrP is also known to participate in bone metastasis and to establish osteolytic bone lesions in metastatic sites, even in the absence of hypercalcemia or increased plasma PTHrP concentration (13–15).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Humoral hypercalcemia of malignancy (HHM) is caused most commonly by the humoral action of PTHrP, which is released by tumor cells (9, 10, 12). Malignant ameloblastoma is occasionally accompanied by hypercalcemia with or without metastasis, and several cases have been ascribed to tumor‐derived PTHrP (16, 17, 48, 49). Tumor‐derived PTHrP is also known to participate in bone metastasis and to establish osteolytic bone lesions in metastatic sites, even in the absence of hypercalcemia or increased plasma PTHrP concentration (13–15).…”
Section: Discussionmentioning
confidence: 99%
“…Production of PTHrP by neoplastic cells has been recognized in malignant tumors commonly associated with HHM, such as adult T cell lymphoma/leukemia (ATLL), pulmonary squamous cell carcinoma, and renal cell carcinoma (9, 10, 12) as well as in malignancies frequently associated with bone metastasis, such as breast and prostate carcinomas (13–15). Several cases of malignant ameloblastoma with hypercalcemia have been attributed to PTHrP (16, 17). Osteoclast differentiation factor (ODF)/receptor activator of nuclear factor‐κB ligand (RANKL) is a cell membrane‐bound and soluble molecule of the tumor necrosis factor (TNF) superfamily (6, 18).…”
mentioning
confidence: 99%
“…Death is not so uncommon in cases of malignant ameloblastoma. Seward et al [12] reported a case of death in a patient with ameloblastoma metastasized to the lung 11 years after resection of the primary tumor on the face. According to the authors, death occurred as a result of the spinal and hepatic spread of the tumor, and thrombosis of the renal veins.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, Seward et al (1975) have reported a case of ameloblastoma associated with renal calculi and hypercalcemia. In our cases no evidence of real aggressive growth or distant metastasis was found, nor was there any sign of renal involvement and hypercalcemia.…”
Section: Discussionmentioning
confidence: 99%